Related Experiment Video

Updated: Apr 26, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.7K

The supply of hematology/oncology specialists

Genevieve F Maronge1, Paragi Gururaja Ramnaryan2, Perry G Rigby3

  • 1Fellow in the Section of Hematology/Oncology at Louisiana State University School of Medicine in New Orleans.

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
|July 31, 2014
PubMed

Insights

The United States faces a projected shortage of hematology/oncology specialists. Louisiana

Area of Science:

  • Medical Education
  • Health Workforce Analysis
  • Oncology

Background:

  • National organizations predict a significant shortage of hematology/oncology specialists in the US.
  • Physician supply is influenced by graduate medical education programs and other specialist training.
  • Predicting physician supply is complex due to multiple training pathways and specialties.

Purpose of the Study:

  • To quantitatively assess hematology/oncology physician supply in Louisiana.
  • To compare Louisiana's physician production to national averages.
  • To project the impact of national trends on Louisiana's specialist workforce.

Main Methods:

  • Analysis of four types of hematology/oncology graduate medical education programs.
  • Quantitative data on physician supply presented proportionally to US averages.
  • Comparative analysis of Louisiana's program output against national data.

Main Results:

  • Hematology/oncology physician production in Louisiana mirrors the US average.
  • Louisiana's specialist supply is expected to follow national trends.
  • Complexities in graduate medical education and specialist training impact supply predictions.

Conclusions:

  • Louisiana's hematology/oncology physician supply aligns with the national average.
  • The state is projected to experience a specialist shortage mirroring the US.
  • Increasing patient demand due to population growth and aging will exacerbate shortages.

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

8.6K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

6.1K

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K